These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8042913)

  • 1. Risk factors for spontaneous dyskinesia in schizophrenia.
    Fenton WS; Wyatt RJ; McGlashan TH
    Arch Gen Psychiatry; 1994 Aug; 51(8):643-50. PubMed ID: 8042913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.
    Chatterjee A; Chakos M; Koreen A; Geisler S; Sheitman B; Woerner M; Kane JM; Alvir J; Lieberman JA
    Am J Psychiatry; 1995 Dec; 152(12):1724-9. PubMed ID: 8526237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of spontaneous dyskinesia in schizophrenia.
    Fenton WS
    J Clin Psychiatry; 2000; 61 Suppl 4():10-4. PubMed ID: 10739325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not all that moves is tardive dyskinesia.
    Khot V; Wyatt RJ
    Am J Psychiatry; 1991 May; 148(5):661-6. PubMed ID: 1673323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of spontaneous dyskinesia in schizophrenic and non-schizophrenic psychiatric patients.
    Fenton WS; Blyler CR; Wyatt RJ; McGlashan TH
    Br J Psychiatry; 1997 Sep; 171():265-8. PubMed ID: 9337982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous abnormal involuntary movements in first-episode schizophrenia and schizophreniform disorder: baseline rate in a group of patients from an Irish catchment area.
    Gervin M; Browne S; Lane A; Clarke M; Waddington JL; Larkin C; O'Callaghan E
    Am J Psychiatry; 1998 Sep; 155(9):1202-6. PubMed ID: 9734543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs.
    Peralta V; Moreno-Izco L; Sanchez-Torres A; García de Jalón E; Campos MS; Cuesta MJ
    Schizophr Bull; 2014 Jan; 40(1):214-24. PubMed ID: 23256987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients.
    Janno S; Holi M; Tuisku K; Wahlbeck K
    Am J Psychiatry; 2004 Jan; 161(1):160-3. PubMed ID: 14702266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Historical perspective on movement disorders.
    Friedman JH
    J Clin Psychiatry; 2004; 65 Suppl 9():3-8. PubMed ID: 15189105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality.
    Waddington JL; Youssef HA; Dolphin C; Kinsella A
    Arch Gen Psychiatry; 1987 Oct; 44(10):907-12. PubMed ID: 2889438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia.
    Fenton WS; McGlashan TH
    Am J Psychiatry; 1994 Mar; 151(3):351-6. PubMed ID: 7906493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor behavior abnormalities in drug-naïve patients with schizophrenia spectrum disorders.
    Peralta V; Campos MS; De Jalón EG; Cuesta MJ
    Mov Disord; 2010 Jun; 25(8):1068-76. PubMed ID: 20222137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous and tardive dyskinesias: clinical and laboratory studies.
    Casey DE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):42-7. PubMed ID: 2858480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired glucose tolerance and abnormal movements in patients with schizophrenia.
    Schultz SK; Arndt S; Ho BC; Oliver SE; Andreasen NC
    Am J Psychiatry; 1999 Apr; 156(4):640-2. PubMed ID: 10200749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
    de Jesus Mari J; Lima MS; Costa AN; Alexandrino N; Rodrigues-Filho S; de Oliveira IR; Tollefson GD
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Movements in never-medicated schizophrenics: a preliminary study.
    Fenn DS; Moussaoui D; Hoffman WF; Kadri N; Bentounssi B; Tilane A; Khomeis M; Casey DE
    Psychopharmacology (Berl); 1996 Jan; 123(2):206-10. PubMed ID: 8741945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous dyskinesia in first episode schizophrenia.
    Puri BK; Barnes TR; Chapman MJ; Hutton SB; Joyce EM
    J Neurol Neurosurg Psychiatry; 1999 Jan; 66(1):76-8. PubMed ID: 9886457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nithsdale schizophrenia surveys. X: Obstetric complications, family history and abnormal movements.
    McCreadie RG; Hall DJ; Berry IJ; Robertson LJ; Ewing JI; Geals MF
    Br J Psychiatry; 1992 Jun; 160():799-805. PubMed ID: 1617363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders.
    Fenton WS; McGlashan TH; Victor BJ; Blyler CR
    Am J Psychiatry; 1997 Feb; 154(2):199-204. PubMed ID: 9016268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.